全文获取类型
收费全文 | 119727篇 |
免费 | 11345篇 |
国内免费 | 5386篇 |
专业分类
耳鼻咽喉 | 2141篇 |
儿科学 | 1669篇 |
妇产科学 | 1860篇 |
基础医学 | 12129篇 |
口腔科学 | 3485篇 |
临床医学 | 9937篇 |
内科学 | 15435篇 |
皮肤病学 | 2137篇 |
神经病学 | 450篇 |
特种医学 | 4991篇 |
外国民族医学 | 125篇 |
外科学 | 22509篇 |
综合类 | 20991篇 |
现状与发展 | 28篇 |
预防医学 | 3030篇 |
眼科学 | 433篇 |
药学 | 7575篇 |
32篇 | |
中国医学 | 2565篇 |
肿瘤学 | 24936篇 |
出版年
2024年 | 68篇 |
2023年 | 1639篇 |
2022年 | 2373篇 |
2021年 | 4161篇 |
2020年 | 4025篇 |
2019年 | 3804篇 |
2018年 | 3670篇 |
2017年 | 4001篇 |
2016年 | 4617篇 |
2015年 | 5232篇 |
2014年 | 7894篇 |
2013年 | 7817篇 |
2012年 | 6974篇 |
2011年 | 7525篇 |
2010年 | 6143篇 |
2009年 | 6117篇 |
2008年 | 6313篇 |
2007年 | 6721篇 |
2006年 | 6295篇 |
2005年 | 5673篇 |
2004年 | 4612篇 |
2003年 | 4017篇 |
2002年 | 3428篇 |
2001年 | 3229篇 |
2000年 | 2710篇 |
1999年 | 2135篇 |
1998年 | 1794篇 |
1997年 | 1627篇 |
1996年 | 1490篇 |
1995年 | 1476篇 |
1994年 | 1345篇 |
1993年 | 994篇 |
1992年 | 881篇 |
1991年 | 757篇 |
1990年 | 644篇 |
1989年 | 591篇 |
1988年 | 522篇 |
1987年 | 449篇 |
1986年 | 344篇 |
1985年 | 425篇 |
1984年 | 353篇 |
1983年 | 234篇 |
1982年 | 255篇 |
1981年 | 235篇 |
1980年 | 202篇 |
1979年 | 165篇 |
1978年 | 145篇 |
1977年 | 94篇 |
1976年 | 95篇 |
1975年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
92.
背景 既往对肝癌微血管侵犯病理诊断的重要性重视不够,目前国内外缺乏对微血管侵犯统一的病理诊断标准,也未将微血管侵犯列为病理常规诊断指标。C反应蛋白/白蛋白比值(CAR)作为新型系统性炎性因子,与肝癌的增殖、侵袭转移等恶性生物学行为密切相关。 目的 探讨CAR预测单发小肝癌患者微血管侵犯的价值。 方法 选择2017年6月至2021年6月在新疆医科大学第一附属医院行肝切除术的单个、肿瘤直径≤5 cm的术后病理检查证实为肝癌的患者346例为研究对象。收集患者一般资料,并计算CAR。绘制CAR预测单发小肝癌患者微血管侵犯的受试者工作特征(ROC)曲线,并计算CAR的最佳诊断截点,根据CAR最佳诊断截点将患者进行分组,采用1∶1最近邻居倾向性评分匹配(PSM)法将Logistic模型估计的倾向性评分相近患者进行配对,得到两组间各临床特征比较均衡性较高的样本。比较匹配后两组患者微血管侵犯率,采用Logistic回归分析评估匹配前、后CAR对单发小肝癌患者微血管侵犯的预测价值。 结果 346例患者中微血管侵犯阳性131例(37.9%),微血管侵犯阴性215例(62.1%)。ROC曲线分析结果显示,CAR预测单发小肝癌患者微血管侵犯的灵敏度为82.9%,特异度为76.4%,ROC曲线下面积为0.787〔95%CI(0.697,0.877)〕,最佳诊断截点为0.03。根据CAR最佳诊断截点,将患者分为CAR<0.03组(A组,n=145)和CAR≥0.03组(B组,n=201)。采用1∶1最近邻居PSM法,共92对匹配成功,匹配后两组临床资料均衡。匹配后,B组患者微血管侵犯发生率〔43.5%(40/92)〕高于A组〔13.0%(12/92)〕(χ2=6.314,P=0.013)。采用3种Logistic回归分析结果显示,匹配前、后CAR均为单发小肝癌患者微血管侵犯的独立影响因素(P<0.05)。 结论 CAR作为新型系统性炎症指标,可用于预测单发小肝癌微血管侵犯,当CAR≥0.03时提示单发小肝癌微血管侵犯发生率较高。 相似文献
93.
《Vaccine》2022,40(33):4889-4896
BackgroundDuring the COVID-19 pandemic, the number of hepatitis B virus (HBV) vaccinations among men who have sex with men (MSM) has been considerably lower than before the pandemic. Moreover, less frequent HBV testing and a reduction in numbers of sex partners have been reported. We assessed the impact of these COVID-19-related changes on HBV transmission among MSM in the Netherlands.MethodsWe estimated the changes in sexual activity, HBV testing, and HBV vaccination among MSM during the pandemic from Dutch data. We used a deterministic compartmental model and investigated scenarios with small or large declines in sexual activity, testing, and vaccination for the current phase of the pandemic (without available data). We examined the increase in HBV vaccinations needed to prevent further increase in HBV incidence.ResultsWith a decrease in numbers of sex partners of 15–25% during the first lockdown and 5% during the second lockdown, we found a decline of 6.6% in HBV incidence in 2020, despite a >70% reduction in HBV testing and vaccination during the first lockdown. With numbers of sex partners rebounding close to pre-pandemic level in 2021, and a reduction of 15% in testing and 30% in vaccination in 2021, we found an increase of 1.4% in incidence in 2021 and 3.1% in 2026. With these changes, an increase of ≥60% in HBV vaccinations in 2022 would be needed to bring the HBV incidence in 2023 back to the level that it would have had if the COVID-19-related changes had not occurred.ConclusionsDespite reductions in sexual activity during the COVID-19 pandemic, the decrease in HBV vaccinations may result in a small increase in HBV incidence after 2021, which may persist for years. It is important to restore the vaccination level and limit further increase in HBV transmission among MSM. 相似文献
94.
《Clinical genitourinary cancer》2022,20(3):e217-e226
Background: Intraductal carcinoma and cribriform (IDC/C) tumor features are well-established prognosticators of biochemical recurrence (BCR), metastasis, and prostate cancer (PCa)-specific mortality. However, approximately 70% of PCa patients undergoing a radical prostatectomy are IDC/C negative, yet up-to 20% of these patients progress and experience BCR. Thus, tumor histopathologic characteristics such as IDC/C alone are limited in their ability to predict disease progression. Conversely, several nomograms such as Cancer of the Prostate Risk Assessment-Surgery (CAPRA-S) have been developed to aid in the prognostication of BCR, but not yet widely applied in clinical settings. Materials and methods: In this study, we assessed the combined prognostic utility of IDC/C, and CAPRA-S for BCR in 3 PCa patient cohorts. Results: CAPRA-S+IDC/C improved the predictive accuracy of BCR in all 3 cohorts (P < .001). Specifically, among IDC/C negative cases, CAPRA-S improved the prognostication of BCR in low-risk (Cohort 1; P < .001, Cohort 2; P < .001, Cohort 3; P = .003), intermediate (Cohort 1; P < .001, Cohort 2; P = .006, Cohort 3; P = .03) and high-risk (Cohort 1-3; P < .001) patients. Conversely, IDC/C improved the prognostication of BCR among CAPRA-S low-risk (Cohorts 1; P < .001 and Cohort 3; P = .003) patients. Conclusion: Our results suggest the investigation of histopathological IDC/C features in CAPRA-S low-risk patients and conversely, nomogram CAPRA-S among IDC/C negative patients improves the identification of patients likely to experience BCR, which would otherwise be missed through current assessment regimens. These patients can be offered more intensive monitoring and adjuvant therapies upfront to circumvent the development of recurrent cancer or overtreatment at the time of surgery. 相似文献
95.
Umut ener Ayfer Metin Telliolu Yasemin Durum Polat 《Clinical anatomy (New York, N.Y.)》2022,35(1):103-115
Surface anatomy is fundamental to clinical and surgical practices. As the surface anatomy varies with age, the purpose of this study is to provide age-standardized surface markings for the abdomen in children. A total of 155 abdominal computed tomography scans of healthy children aged 0–18 years were categorized into six groups, and the surface anatomy of the major vascular structures, solid viscera, and anatomical planes in the abdomen was analyzed. The vertebral levels of the celiac trunk, superior mesenteric artery, and hepatic portal vein formation were higher in the youngest age group, whereas the levels of the inferior mesenteric artery, formation of the inferior vena cava, and renal arteries did not differ with age. The right kidney lay between T12 and L3 and the left at T11-L3; however, both kidneys were in lower positions in younger children. The spleen was most commonly located between the 8th and 11th ribs except in toddlers. In all age groups, the hepatic portal vein formation was within the transpyloric plane and the aortic bifurcation was above the supracristal plane. In vivo reassessment of the surface anatomy enables the substantial variability of surface landmarks to be highlighted. This study demonstrates that taking account of age-related variations will increase the accuracy and therefore the clinical relevance of surface anatomy. 相似文献
96.
目的探讨LINC00649/miR-424-5p/IGF1R对内质网应激(ERs)介导的宫颈癌(CC)细胞凋亡的影响。方法从GEO数据库中获取CC相关的数据,并分析差异表达的miRNAs。利用生物信息学数据库预测miR-424-5p的上、下游靶点,将LINC00649和IGF1R纳入研究,随后双荧光素酶实验进一步验证靶向关系。qRT-PCR检测LINC00649、miR-424-5p和IGF1R在CC组织和细胞中的表达水平。CCK-8和流式细胞术分别评估CC细胞增殖和凋亡变化。Western blot检测ERs相关蛋白GRP78、CHOP和Caspase-12的表达。结果与癌旁组织和H8细胞相比,LINC00649和IGF1R在CC组织和细胞中表达上调,而miR-424-5p下调(均P<0.05)。LINC00649的异常高表达与CC患者的预后不良有关,敲减LINC00649可通过促进ERs来抑制CC细胞活力,诱导细胞凋亡(均P<0.05)。LINC00649吸附miR-424-5p上调IGF1R的表达。miR-424-5p抑制剂或过表达IGF1R均可部分逆转敲减LINC00649对CC细胞的影响(均P<0.05)。结论 LINC00649能够通过miR-424-5p/IGF1R抑制CC细胞的ERs过程进而减少细胞凋亡,提高细胞活力。 相似文献
97.
98.
《Cirugía espa?ola》2023,101(2):116-122
IntroductionMetastasis is remaining one of the major problems in cancer treatment. Like many other malignancies, urogenital tumors originating from kidney, prostate, testes, and bladder tend to metastasize to the lungs.The aim of this retrospective study is to evaluate the operative results and prognosis of pulmonary metastasectomy in patients with primary urogenital tumors.MethodsThis study was approved by the local ethical committee. We retrospectively analyzed the surgical and oncological results of patients who underwent lung resections for urogenital cancer metastases in our department between 2002 and 2018. Demographic data and clinicopathological features were extracted from the medical records. Survival outcomes according to cancer subtypes and early postoperative results of VATS and thoracotomy were analyzed.Results22 out of 126 patients referred for pulmonary metastasectomy to our department had metastases from urogenital tumors. These patients consisted of 17 males and five females. Their metastasis originated from renal cell carcinoma (RCC; n = 9), bladder tumor (n = 7), testis tumors (n = 4), and prostate cancer (n = 2). There was no intraoperative complication. Postoperative complications were seen in 2 patients.ConclusionsAlthough pulmonary metastasectomy in various types of tumors is well known and documented, the data is limited for metastases of urogenital cancers in the literature. Despite the limitations of this study, we aim to document our promising results of pulmonary metastasectomy in patients with primary urogenital tumors and wanted to emphasize the role of minimally invasive approaches. 相似文献
99.
100.